Here, we review the research progress in the knowledge of Gal-3, including its origin, its biological and pathobiological functions in AD, and the subsequent issues in clinical practice, such as use in AD diagnosis and therapy. This evidence concerns the gene LGALS3 and Alzheimer disease.